Following the success of the first generation of monoclonal antibody blockbusters, second-generation antibodies were recently approved. In addition, many third-generation antibodies designed to ...

Monoclonal antibodies, or mAbs, are important tools in medicine. These laboratory-made proteins are widely used in treatments for diseases such as cancer, Alzheimer's disease, autoimmune disorders and ...

View Full Profile. Learn about our Editorial Policies. For decades, researchers fixated on the extraordinary potential nestled within the human immune system, particularly the formidable prowess of ...

Changes in glycosylation are often associated with ... intracellular sialic acid levels is untenable by current lectin or antibody methods. In a cellular model system these mutations can be ...

IgG inhibition of a monoclonal antibody therapy can help with the selected deactivation of serum IgG with EndoS. Peptide glycosylation can be achieved using a two-step process involving EndoA or ...

While common sense may suggest that antibodies that do not neutralize the SARS-CoV-2 virus are of little value, recent studies show they can still confer protection against infection. Monoclonal ...

Antibodies bind to specific antigens on pathogens. This means that only one type of antibody will bind to a matching antigen. For example, an antibody that can recognise an antigen on the ...

Recombinant antibodies are invented antibodies formed by using recombinant DNA technology. While traditional monoclonal ...

No writing assistance was utilized in the production of this manuscript. Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA).

Antibodies bind to specific antigens on pathogens. This means that only one type of antibody will bind to a matching antigen. Scientists discovered that we could make antibodies to bind to ...

From left, Florida State University faculty researcher Fanny C. Liu and Christian Bleiholder, a professor in the Department of Chemistry and ...